Helix Biopharma Corp. (TSE:HBP) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Helix BioPharma Corp., a clinical-stage biopharmaceutical company, has announced a private placement of CAD$1.915 million to support its immune-oncology therapy development. Additionally, the company is working to rectify the late filing of its interim financial statements, which has resulted in a management cease trade order by the Ontario Securities Commission, not affecting shareholder trading rights. The company assures there are no undisclosed material changes or insolvency proceedings currently underway.
For further insights into TSE:HBP stock, check out TipRanks’ Stock Analysis page.
